Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety、Immunogenicity”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05087056
What this trial is testing

Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 305
Large-scale testing (Phase 3)UnknownNCT04659239
What this trial is testing

The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

Who this might be right for
COVID-19
Chinese Academy of Medical Sciences 34,020
Testing effectiveness (Phase 2)Study completedNCT04622592
What this trial is testing

Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older

Who this might be right for
Influenza
Medicago 209
Early research (Phase 1)Not Yet RecruitingNCT07789964
What this trial is testing

Compare the Pharmacokinetics, Safety, Tolerability, and Immunogenicity of SB35 (Proposed Ixekizumab Biosimilar) to Taltz in Healthy Participants

Who this might be right for
Healthy
Samsung Bioepis Co., Ltd. 174
Early research (Phase 1)UnknownNCT03806699
What this trial is testing

Phase 1 Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Adolescent

Who this might be right for
Tuberculosis
Quratis Inc. 36
Early research (Phase 1)Study completedNCT01640652
What this trial is testing

MenPF-1 - A New Vaccine Against Meningococcal Disease

Who this might be right for
Serogroup B Meningococcal Disease
University of Oxford 52
Testing effectiveness (Phase 2)Looking for participantsNCT07628049
What this trial is testing

Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults

Who this might be right for
Respiratory Syncytial Virus Infections+Metapneumovirus
GlaxoSmithKline 1,456
Early research (Phase 1)Study completedNCT02797236
What this trial is testing

SF2a-TT15 Conjugate Vaccine in Healthy Adult Volunteers

Who this might be right for
ShigellosisBacillary Dysentery
Institut Pasteur 64
Testing effectiveness (Phase 2)Study completedNCT02037984
What this trial is testing

Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)

Who this might be right for
Streptococcus Pneumoniae InfectionPneumococcal Infections
Merck Sharp & Dohme LLC 341
Large-scale testing (Phase 3)Study completedNCT00255047
What this trial is testing

Safety and Immune Response of Different Pediatric Combination Vaccines.

Who this might be right for
DiphtheriaPolioPertussis
Sanofi Pasteur, a Sanofi Company 2,167
Post-approval studies (Phase 4)Study completedNCT04450498
What this trial is testing

Demonstrate Non-inferior Immunogenicity of Yuxi Walvax MPV ACYW® Vaccine in Healthy Subjects Aged 2-10 Years

Who this might be right for
Neisseria Meningitides Meningitis
Walvax Biotechnology Co., Ltd. 260
Early research (Phase 1)Looking for participantsNCT07464314
What this trial is testing

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

Who this might be right for
Influenza, Human+COVID-19
GlaxoSmithKline 225
Testing effectiveness (Phase 2)Study completedNCT01353534
What this trial is testing

Open-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 Vaccine

Who this might be right for
Healthy
Intercell USA, Inc. 276
Early research (Phase 1)Looking for participantsNCT06948799
What this trial is testing

Evaluate the Safety and Tolerability of Single and Multiple Dose of STSP-0902 in Healthy Subjects

Who this might be right for
Oligozoospermia
Staidson (Beijing) Biopharmaceuticals Co., Ltd 64
Large-scale testing (Phase 3)Study completedNCT05543616
What this trial is testing

Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

Who this might be right for
SARS-CoV-2 VirusSevere Acute Respiratory Syndrome Coronavirus 2COVID-19
BioNTech SE 4,338
Testing effectiveness (Phase 2)Active Not RecruitingNCT06594146
What this trial is testing

Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
Keymed Biosciences Co.Ltd 62
Early research (Phase 1)Looking for participantsNCT07059403
What this trial is testing

SN2001 Dose, Safety & Immunogenicity in Healthy Adults

Who this might be right for
Chronic Hepatitis B Infection
Chimivac INC 36
Early research (Phase 1)Ended earlyNCT03422094
What this trial is testing

Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Who this might be right for
Glioblastoma
Washington University School of Medicine 3
Large-scale testing (Phase 3)Study completedNCT00337818
What this trial is testing

Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women

Who this might be right for
Papillomavirus Type 16/18 InfectionCervical Intraepithelial Neoplasia
GlaxoSmithKline 770
Early research (Phase 1)Study completedNCT01957280
What this trial is testing

Study to Assess Pharmacokinetics, Immunogenicity and Safety/Tolerability of Patritumab (U3-1287)

Who this might be right for
Solid Tumors
Daiichi Sankyo 17
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation